These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 29857020)
21. TRPV4-dependent induction of a novel mammalian cold-inducible protein SRSF5 as well as CIRP and RBM3. Fujita T; Higashitsuji H; Higashitsuji H; Liu Y; Itoh K; Sakurai T; Kojima T; Kandori S; Nishiyama H; Fukumoto M; Fukumoto M; Shibasaki K; Fujita J Sci Rep; 2017 May; 7(1):2295. PubMed ID: 28536481 [TBL] [Abstract][Full Text] [Related]
22. Downregulation of splicing factor SRSF3 induces p53β, an alternatively spliced isoform of p53 that promotes cellular senescence. Tang Y; Horikawa I; Ajiro M; Robles AI; Fujita K; Mondal AM; Stauffer JK; Zheng ZM; Harris CC Oncogene; 2013 May; 32(22):2792-8. PubMed ID: 22777358 [TBL] [Abstract][Full Text] [Related]
23. SRSF3: Newly discovered functions and roles in human health and diseases. More DA; Kumar A Eur J Cell Biol; 2020 Aug; 99(6):151099. PubMed ID: 32800280 [TBL] [Abstract][Full Text] [Related]
24. Cellular differentiation state modulates the mRNA export activity of SR proteins. Botti V; McNicoll F; Steiner MC; Richter FM; Solovyeva A; Wegener M; Schwich OD; Poser I; Zarnack K; Wittig I; Neugebauer KM; Müller-McNicoll M J Cell Biol; 2017 Jul; 216(7):1993-2009. PubMed ID: 28592444 [TBL] [Abstract][Full Text] [Related]
25. Mutually exclusive acetylation and ubiquitylation of the splicing factor SRSF5 control tumor growth. Chen Y; Huang Q; Liu W; Zhu Q; Cui CP; Xu L; Guo X; Wang P; Liu J; Dong G; Wei W; Liu CH; Feng Z; He F; Zhang L Nat Commun; 2018 Jun; 9(1):2464. PubMed ID: 29942010 [TBL] [Abstract][Full Text] [Related]
27. Oncogenic SRSF3 in health and diseases. Jia R; Zheng ZM Int J Biol Sci; 2023; 19(10):3057-3076. PubMed ID: 37416784 [TBL] [Abstract][Full Text] [Related]
28. SRSF3, a Splicer of the PKM Gene, Regulates Cell Growth and Maintenance of Cancer-Specific Energy Metabolism in Colon Cancer Cells. Kuranaga Y; Sugito N; Shinohara H; Tsujino T; Taniguchi K; Komura K; Ito Y; Soga T; Akao Y Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30279379 [TBL] [Abstract][Full Text] [Related]
29. Oncogenic splicing factor SRSF3 regulates ILF3 alternative splicing to promote cancer cell proliferation and transformation. Jia R; Ajiro M; Yu L; McCoy P; Zheng ZM RNA; 2019 May; 25(5):630-644. PubMed ID: 30796096 [TBL] [Abstract][Full Text] [Related]
30. SRSF3 and hnRNP H1 regulate a splicing hotspot of HER2 in breast cancer cells. Gautrey H; Jackson C; Dittrich AL; Browell D; Lennard T; Tyson-Capper A RNA Biol; 2015; 12(10):1139-51. PubMed ID: 26367347 [TBL] [Abstract][Full Text] [Related]
31. SRSF5: a novel marker for small-cell lung cancer and pleural metastatic cancer. Kim HR; Lee GO; Choi KH; Kim DK; Ryu JS; Hwang KE; Na KJ; Choi C; Kuh JH; Chung MJ; Lee MK; So HS; Yoon KH; Park MC; Na KS; Kim YS; Park DS Lung Cancer; 2016 Sep; 99():57-65. PubMed ID: 27565915 [TBL] [Abstract][Full Text] [Related]
32. SRSF3/AMOTL1 splicing axis promotes the tumorigenesis of nasopharyngeal carcinoma through regulating the nucleus translocation of YAP1. Xu XC; Jiang JX; Zhou YQ; He S; Liu Y; Li YQ; Wei PP; Bei JX; Sun J; Luo CL Cell Death Dis; 2023 Aug; 14(8):511. PubMed ID: 37558679 [TBL] [Abstract][Full Text] [Related]
33. SRSF3 promotes pluripotency through Ratnadiwakara M; Archer SK; Dent CI; Ruiz De Los Mozos I; Beilharz TH; Knaupp AS; Nefzger CM; Polo JM; Anko ML Elife; 2018 May; 7():. PubMed ID: 29741478 [TBL] [Abstract][Full Text] [Related]
34. Loss of SRSF3 in Cardiomyocytes Leads to Decapping of Contraction-Related mRNAs and Severe Systolic Dysfunction. Ortiz-Sánchez P; Villalba-Orero M; López-Olañeta MM; Larrasa-Alonso J; Sánchez-Cabo F; Martí-Gómez C; Camafeita E; Gómez-Salinero JM; Ramos-Hernández L; Nielsen PJ; Vázquez J; Müller-McNicoll M; García-Pavía P; Lara-Pezzi E Circ Res; 2019 Jul; 125(2):170-183. PubMed ID: 31145021 [TBL] [Abstract][Full Text] [Related]
35. Ebp1 activates podoplanin expression and contributes to oral tumorigenesis. Mei Y; Zhang P; Zuo H; Clark D; Xia R; Li J; Liu Z; Mao L Oncogene; 2014 Jul; 33(29):3839-50. PubMed ID: 23975429 [TBL] [Abstract][Full Text] [Related]
36. PPM1G promotes the progression of hepatocellular carcinoma via phosphorylation regulation of alternative splicing protein SRSF3. Chen D; Zhao Z; Chen L; Li Q; Zou J; Liu S Cell Death Dis; 2021 Jul; 12(8):722. PubMed ID: 34290239 [TBL] [Abstract][Full Text] [Related]
37. Splicing factor SRSF3 represses translation of p21 Kim J; Park RY; Kee Y; Jeong S; Ohn T Cell Death Dis; 2022 Nov; 13(11):933. PubMed ID: 36344491 [TBL] [Abstract][Full Text] [Related]
38. Splicing factor SRSF3 promotes the progression of cervical cancer through regulating DDX5. Che Y; Bai M; Lu K; Fu L Mol Carcinog; 2023 Feb; 62(2):210-223. PubMed ID: 36282044 [TBL] [Abstract][Full Text] [Related]
39. The SRSF3-MBNL1-Acin1 circuit constitutes an emerging axis to lessen DNA fragmentation in colorectal cancer via an alternative splicing mechanism. Chen YS; Liu CW; Lin YC; Tsai CY; Yang CH; Lin JC Neoplasia; 2020 Dec; 22(12):702-713. PubMed ID: 33142236 [TBL] [Abstract][Full Text] [Related]
40. Factors affecting the expression and stability of full-length and truncated SRSF3 proteins in human cancer cells. Sue SH; Liu ST; Huang SM Sci Rep; 2024 Jun; 14(1):14397. PubMed ID: 38909100 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]